Micron Technology Surpasses 1 Trillion Market Cap on AI Memory Boom US Job Market Tightens for International Graduates Amid Immigration Rule Shifts BofA Analyst Raises Philip Morris International Price Target Signaling Confidence in SmokeFree Strategy US Pressure Campaign Against Cuba May Signal Heightened Geopolitical Risks Genpact CEO Says AI Could Reduce IT Workload and Jobs Requiring Higher Skill Sets Bitcoin Retreats to 74500 Poised for Weekly Decline as Geopolitical Concerns Mount ISPR Q1 2026 Earnings Significant EPS Miss Drives Stock Decline RPT Q1 2026 Earnings Significant EPS Miss Amid Challenging Real Estate Environment ARM Q1 2026 Earnings EPS Beats Estimates Amid Strong Licensing Demand STNE Q1 2026 Earnings EPS Misses Estimates by 391 Stock Edges Higher IRTC Q1 2026 Earnings Narrowing Losses Beat Expectations as Operating Discipline Drives Results LANDO Q1 2026 Earnings Preferred Stock Stays Steady With Slight EPS Beat GoldMining Inc GLDG Slips 18 as Support Level Tested Village Farms International Faces Pressure Near Support as Cannabis Sector Struggles Andretti Acquisition Corp II POLE Holds Steady Near Trust Value Amid Minimal Volatility Launch Two Acquisition Corp LPBB Holds Steady Near Trust Value with Minimal Price Movement Enovis Corporation ENOV Faces Selling Pressure Near Resistance Support in Focus South Korea Deputy PM Urges AI Wealth to Benefit Public Amid Samsung Labor Unrest SOFI Q1 2026 Earnings Narrow Earnings Miss Sends Stock Slightly Lower COOTW Warrants Remain Stagnant at 002 Key Levels and Outlook PriceSmart Inc PSMT Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher Corcept Therapeutics CORT Q1 2026 Earnings Severe Earnings Miss Overshadows Operational Developments Mirion Technologies MIR Q1 2026 Earnings EPS Beats Estimates Despite Sparse Revenue Disclosure Quantum Biopharma Ltd QNTM Q4 2025 Earnings Biotech Firm Reports Wider Loss Amid Lack of Revenue Visibility CLLS Q1 2026 Earnings NarrowerThanExpected Loss as GeneEditing Pipeline Advances FRHC Q1 2026 Earnings EPS of 125 Reported Amid Mixed Market Signals Lyell Immunopharma LYEL Q1 2026 Earnings Narrower Loss Beats Estimates as Biotech Advances Pipeline